Hepatitis C is curable — a single course of pills, 8 to 12 weeks, cures more than 95% of people. And in 2026, most people in the United States can get that cure at little or no cost, whatever their insurance situation.
This tool asks four quick questions and points you to the program most likely to get you treated — with the exact next step to take. No name, no email, nothing saved. About 45 seconds.
How this tool decides what to show you
The screener matches your coverage type, household size, and income against the programs that help people get cured of hepatitis C, then lists them in the order most likely to work for you. It doesn’t decide whether you qualify; only the programs can do that. What it removes is the hardest part: knowing where to start and what to actually do next.
For hepatitis C, the paths are different from most cost problems. If you have Medicaid, your coverage is usually the fastest route — every state now covers treatment. If you’re uninsured, the manufacturer programs from Gilead and AbbVie can provide the medicine free. If you have private insurance, co-pay savings programs can cut the cost sharply. If you get care through the VA or the Indian Health Service, that system treats hepatitis C directly, so the tool points you there. And if you already have Medicaid, your coverage is usually the simpler, faster path than a manufacturer program, so the tool leads you there first.
- It’s a cure, not lifelong treatment. A single 8-to-12-week course of pills cures more than 95% of people — then you’re done.
- Every state’s Medicaid now covers it. As of 2026, no state requires sobriety, and no state makes you wait for liver damage first.
- You don’t need a specialist. Most states let a regular primary-care provider prescribe the cure.
- Uninsured often means free. Gilead’s program helps up to about 500% of the poverty level and AbbVie’s up to about 600% — roughly $90,000 a year for one person.
Common questions
Can I get hepatitis C treatment for free if I have no insurance?
Often, yes. If you’re uninsured, Gilead’s Support Path (for Epclusa, Harvoni, Sovaldi, and Vosevi) and AbbVie’s program (for Mavyret) provide hepatitis C medicine at no cost to patients who qualify, generally up to about 500% (Gilead) or 600% (AbbVie) of the federal poverty level. Because hepatitis C is now curable in 8 to 12 weeks, this is usually a one-time course, not an ongoing cost.
Does Medicaid cover hepatitis C treatment?
Yes. As of 2026, all 50 states and DC cover hepatitis C treatment through Medicaid. The old barriers have largely fallen: no state still requires a period of sobriety, and no state still requires advanced liver damage before treating. Some states require prior-authorization paperwork, but that’s a step, not a denial. If you have Medicaid, that’s usually your most direct path to a cure.
Do I have to be sober to get hepatitis C treatment?
No. As of 2026, no U.S. state Medicaid program requires sobriety before hepatitis C treatment, and current guidelines recommend treating everyone regardless of alcohol or drug use. Active substance use is not a reason to be denied a cure. If a provider or plan says otherwise, that conflicts with current national policy, and you can appeal or seek care through a community clinic.
How much does hepatitis C treatment cost with insurance?
It varies, but assistance can bring it close to zero. With commercial or job-based insurance, the Gilead and AbbVie co-pay savings programs can lower your out-of-pocket cost, sometimes to as little as $5 per month, though these co-pay cards can’t be used if you have Medicare or Medicaid. If your plan denies the medication, a prescriber appeal often succeeds because treatment is now the standard of care.
What are the main hepatitis C medications?
The main direct-acting antiviral regimens are Epclusa (sofosbuvir/velpatasvir) and Mavyret (glecaprevir/pibrentasvir), which treat all genotypes, plus Harvoni and Vosevi for specific cases. Lower-cost authorized generics of Epclusa and Harvoni also exist. All are pills taken for 8 to 12 weeks and cure more than 95% of patients. Your prescriber picks the regimen based on your genotype, liver health, and prior treatment.
Does this tool save my name, email, or answers?
No. Nothing you enter is stored or sent anywhere. The tool runs entirely inside your browser — no account, no submission form, no logging, not even anonymous logging. Close the page and your answers are gone.
Do I need a specialist to get hepatitis C treatment?
Usually not anymore. Most states have removed rules limiting hepatitis C prescribing to liver or infectious-disease specialists, so primary-care providers can now treat it in many places. If you don’t have a prescriber, a Ryan White clinic or community health center can test and treat you, often on a sliding-fee scale. Find one at findahealthcenter.hrsa.gov.
Is hepatitis C treatment really a cure?
Yes. Modern direct-acting antiviral pills cure more than 95% of people in a single 8-to-12-week course. Cure means the virus is undetectable in your blood twelve weeks after finishing treatment, called a sustained virologic response. Unlike some chronic conditions, this is a one-time treatment, not a lifelong medication — though you can be reinfected if exposed again.
Is this a pharmacy, and are you giving me medical advice?
No. SunnyPharma is an independent, physician-reviewed health-cost-education resource — not a pharmacy and not a provider. This tool helps you find and navigate treatment-access programs. It doesn’t dispense medication, determine eligibility, or replace advice from your own doctor or case manager.
How we built this tool.
Program facts are verified against primary sources: Gilead Support Path and AbbVie patient-assistance documentation; the 2026 HHS Poverty Guidelines; the Center for Health Law and Policy Innovation / NVHR State of Hepatitis C (2026) Medicaid access data; and the CANN HIV/HCV Co-Infection Watch (April 2026) confirming all 50 states cover treatment with no sobriety or fibrosis restrictions. State Medicaid rules and manufacturer terms change, so the tool routes to authoritative trackers rather than hard-coding figures. Facts current for 2026; reverify after Jan 2027.
Read our editorial policy →Sources
- Gilead Support Path (Epclusa, Harvoni, Sovaldi, Vosevi): mysupportpath.com · 1-855-769-7284
- AbbVie patient assistance (Mavyret): abbvie.com · 1-877-628-9738
- State of Hepatitis C — Medicaid access tracker (CHLPI & NVHR, 2026): stateofhepc.org
- CANN HIV/HCV Co-Infection Watch, April 2026 (all-state coverage, no sobriety/fibrosis): hiv-hcv-watch.com
- HRSA Find a Health Center: findahealthcenter.hrsa.gov
- CDC Hepatitis C information: cdc.gov/hepatitis-c
- 2026 HHS Poverty Guidelines, ASPE: aspe.hhs.gov
Medical & eligibility disclaimer: Educational content only — not medical, legal, or financial advice, and not a determination of eligibility. Program rules change; confirm current details with each program before acting. Consult a licensed healthcare provider or your case manager about your treatment.